Evidence map›Paper›PMID 39943974›Full record

ArticleJournal of contemporary brachytherapy2024

Nomogram prediction model for overall survival of late-stage lung cancer patients undergoing iodine-125 particle implantation brachytherapy.

Tingting Ding, Xiangyan Ge, Shanhu Hao, Zhiguo Wang, Wenwen Zhang, Guoxu Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of contemporary brachytherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tingting Ding *Department of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.
Xiangyan Ge *Department of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.
Shanhu HaoDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.
Zhiguo WangDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.
Wenwen ZhangDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.
Guoxu ZhangDepartment of Nuclear Medicine, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to explore the overall survival (OS) rate of late-stage lung cancer patients after receiving iodine-125 ( Material and methods: 436 late-stage lung cancer patients who underwent Results: The results of univariate and multivariate Cox proportional hazards model analyses of OS time showed that smoking, lung atelectasis, superior vena cava obstruction syndrome, and surgical time were significantly associated with OS of patients, and were independent influencing factors. The results of univariate and multivariate Cox proportional hazards model analyses of PFS demonstrated that planning target volume, maximum dose, average dose, pre-operative D Conclusions: This study revealed the potential benefits of

Indexed as

advanced lung cancernomogram chartparticle implantation brachytherapyprediction modelsurvival analysis

Identifiers

PMID39943974
PMCPMC11812134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.